Description
The 2025 updates to the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) in the United States are effective from October 1, 2024, through September 30, 2025. These updates include 252 new codes, 36 deletions, and 13 revisions, bringing the total to 74,260 codes.
This comprehensive webinar is designed to ensure healthcare professionals are fully prepared to apply these changes accurately, minimizing delays in claim processing and reimbursement.
This session will cover all updated guidelines and focus on specific code categories that may impact code selection. Key chapters are highlighted, ensuring relevance across specialties so you can confidently adapt to the new standards in your field.
Learning Objectives:
- Understand the latest guideline changes and what they mean for your coding practices.
- Explore chapter-specific additions and updates that may affect your code choices.
- Gain insights to stay prepared with new code details, reducing processing delays.
- Coordinate with software vendors to integrate updates into your systems seamlessly.
Key Highlights of the 2025 ICD-10-CM Updates:
- Neoplasms:
- Introduction of 63 new codes for lymphoma, specifying when the disease is "in remission."
- Endocrine, Nutritional, and Metabolic Diseases:
- Addition of codes for presymptomatic Type 1 diabetes mellitus (E10.A-), hypoglycemia levels (E16.A-), and obesity classifications (E66.811-E66.813).
- Mental, Behavioral, and Neurodevelopmental Disorders:
- Enhanced specificity in eating disorder codes, differentiating between types and severity levels.
- Diseases of the Digestive System:
- Expansion of codes for anal fistula classifications by site and type, providing greater detail on the complexity of the condition.
- Diseases of the Musculoskeletal System and Connective Tissue:
- Addition of codes for synovitis and tenosynovitis, specifying location and laterality.
- Official Coding Guidelines:
- Minor adjustments, including updates related to breast implant-associated anaplastic large cell lymphoma and presymptomatic Type 1 diabetes mellitus.
Why Attend?
Staying current with these updates is critical, as missed information or unimplemented changes can lead to reimbursement delays. By being proactive and knowledgeable, you can better align with coding requirements for claims with discharge dates of October 1 and beyond.
Who Should Attend?
- Revenue Cycle Managers & staff
- Billers
- Coders
- Clinical Documentation Staff
- Finance Managers
- Denial Management Staff
- Physicians
- Mid-Level Providers
- Claims Follow Up Staff
